Antitumor activity of HER1/EGFR tyrosine kinase inhibitor erlotinib, alone and in combination with CPT-11 (irinotecan) in human colorectal cancer xenograft models

✍ Scribed by Jianping Chen; Melissa Smith; Kenneth Kolinsky; Violeta Adames; Nila Mehta; Luke Fritzky; Mohammad Rashed; Eric Wheeldon; Michael Linn; Brian Higgins

• Publisher: Springer
• Year: 2006
• Tongue: English
• Weight: 480 KB
• Volume: 59
• Category: Article
• ISSN: 0344-5704
• DOI: 10.1007/s00280-006-0320-8